MX2017006513A - Compuestos de tipo 1,9-diazaespiroundecano con actividad multimodal contra el dolor. - Google Patents
Compuestos de tipo 1,9-diazaespiroundecano con actividad multimodal contra el dolor.Info
- Publication number
- MX2017006513A MX2017006513A MX2017006513A MX2017006513A MX2017006513A MX 2017006513 A MX2017006513 A MX 2017006513A MX 2017006513 A MX2017006513 A MX 2017006513A MX 2017006513 A MX2017006513 A MX 2017006513A MX 2017006513 A MX2017006513 A MX 2017006513A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- activity against
- against pain
- diazaspiro undecane
- undecane compounds
- Prior art date
Links
- RSJKGSCJYJTIGS-BJUDXGSMSA-N undecane Chemical class CCCCCCCCCC[11CH3] RSJKGSCJYJTIGS-BJUDXGSMSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000000144 pharmacologic effect Effects 0.000 abstract 2
- 230000009977 dual effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14382466 | 2014-11-21 | ||
| PCT/EP2015/002333 WO2016078771A1 (en) | 2014-11-21 | 2015-11-20 | 1,9-diazaspiro undecane compounds having multimodal activity against pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2017006513A true MX2017006513A (es) | 2018-04-11 |
Family
ID=51982510
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017006513A MX2017006513A (es) | 2014-11-21 | 2015-11-20 | Compuestos de tipo 1,9-diazaespiroundecano con actividad multimodal contra el dolor. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10022359B2 (enExample) |
| EP (1) | EP3221315A1 (enExample) |
| JP (1) | JP2017535566A (enExample) |
| CN (1) | CN107001368B (enExample) |
| CA (1) | CA2967857A1 (enExample) |
| MX (1) | MX2017006513A (enExample) |
| WO (1) | WO2016078771A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201615643A (zh) | 2014-06-02 | 2016-05-01 | 伊史帝夫博士實驗室股份有限公司 | 具有多重模式抗疼痛活性之１－氧雜－４，９－二氮雜螺十一烷化合物之烷基與芳基衍生物 |
| SI3365346T1 (sl) | 2015-10-23 | 2020-04-30 | Esteve Pharmaceuticals, S.A. | Spojine oksa diazaspiro s protibolečinskim delovanjem |
| WO2018153545A1 (en) * | 2017-02-27 | 2018-08-30 | Laboratorios Del Dr. Esteve, S.A. | Piperidine methanone derivatives having multimodal activity against pain |
| IL299091A (en) * | 2020-08-14 | 2023-02-01 | Novartis Ag | Heteroaryl substituted spiropiperidinyl derivatives and their medicinal uses |
| WO2024105225A1 (en) | 2022-11-18 | 2024-05-23 | Universitat De Barcelona | Synergistic combinations of a sigma receptor 1 (s1r) antagonist and a soluble epoxide hydrolase inhibitor (sehi) and their use in the treatment of pain |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993013101A1 (fr) * | 1991-12-27 | 1993-07-08 | Yoshitomi Pharmaceutical Industries, Ltd. | Compose de pyridonecarboxylate, son utilisation pharmaceutique et compose spiro |
| GB9202238D0 (en) * | 1992-02-03 | 1992-03-18 | Wellcome Found | Compounds |
| AU4274401A (en) * | 2000-03-24 | 2001-10-03 | Meiji Seika Kaisha | Diphenylalkylamine derivatives useful as opioid delta receptor agonists |
| ES2251317B1 (es) | 2004-10-14 | 2007-03-16 | Laboratorios Del Dr. Esteve, S.A. | Inhibidores del receptor sigma. |
| EP2020414A1 (en) | 2007-06-20 | 2009-02-04 | Laboratorios del Dr. Esteve S.A. | spiro[piperidine-4,4'-thieno[3,2-c]pyran] derivatives and related compounds as inhibitors of the sigma receptor for the treatment of psychosis |
| IT1394217B1 (it) * | 2009-05-15 | 2012-06-01 | Chemi Spa | Metodo di preparazione di fesoterodina e/o fesoterodina fumarato. |
| US20120101110A1 (en) * | 2010-10-26 | 2012-04-26 | Sangamesh Badiger | Diaza-spiro[5.5]undecanes |
| JP6402115B2 (ja) * | 2013-02-04 | 2018-10-10 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | 神経学的疾患および状態の処置に有用なスピロ−キナゾリノン誘導体 |
| EP3083595B1 (en) * | 2013-12-20 | 2020-05-27 | Esteve Pharmaceuticals, S.A. | Piperidine compounds having multimodal activity against pain |
| TW201615642A (zh) * | 2014-06-02 | 2016-05-01 | 伊史帝夫博士實驗室股份有限公司 | 具有多重模式抗疼痛活性的１－氧雜－４，９－二氮雜螺十一烷化合物之醯胺衍生物 |
| WO2016078770A1 (en) * | 2014-11-21 | 2016-05-26 | Laboratorios Del Dr. Esteve, S.A. | Spiro-isoquinoline-1,4'-piperidine compounds having multimodal activity against pain |
-
2015
- 2015-11-20 WO PCT/EP2015/002333 patent/WO2016078771A1/en not_active Ceased
- 2015-11-20 CN CN201580062701.0A patent/CN107001368B/zh not_active Expired - Fee Related
- 2015-11-20 JP JP2017527365A patent/JP2017535566A/ja not_active Ceased
- 2015-11-20 CA CA2967857A patent/CA2967857A1/en not_active Abandoned
- 2015-11-20 MX MX2017006513A patent/MX2017006513A/es unknown
- 2015-11-20 US US15/527,458 patent/US10022359B2/en not_active Expired - Fee Related
- 2015-11-20 EP EP15801672.5A patent/EP3221315A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CN107001368A (zh) | 2017-08-01 |
| JP2017535566A (ja) | 2017-11-30 |
| US20170354648A1 (en) | 2017-12-14 |
| WO2016078771A1 (en) | 2016-05-26 |
| CN107001368B (zh) | 2019-05-31 |
| EP3221315A1 (en) | 2017-09-27 |
| US10022359B2 (en) | 2018-07-17 |
| CA2967857A1 (en) | 2016-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202004557B (en) | Modulatory polynucleotides | |
| MX2023010042A (es) | Polinucleotidos moduladores. | |
| PH12016502307B1 (en) | Alkyl derivatives of 1-oxa-4,9-diazaspiro undecane compounds having multimodal activity against pain | |
| MX2017006437A (es) | Compuestos espiroisoquinolin-1,4'-piperidinicos con actividad multimodal contra el dolor. | |
| PH12018500586A1 (en) | Farnesoid x receptor agonists and uses thereof | |
| MY187540A (en) | Compounds active towards bromodomains | |
| WO2015112806A3 (en) | Diaryl macrocycles as modulators of protein kinases | |
| TW201613901A (en) | New compounds | |
| MX2016015762A (es) | Derivados de alquilo y arilo de compuestos de 1-oxa-4,9-diazaspiro undecano que tienen actividad multimodal contra el dolor. | |
| PH12016500978A1 (en) | Piperazine derivatives having multimodal activity against pain | |
| MX2018000419A (es) | Derivados de amida sustituida que tienen actividad multimodal contra el dolor. | |
| MX2016006604A (es) | Derivados de piperidina con actividad multimodal contra el dolor. | |
| AU2018253600A1 (en) | Dosage forms and therapeutic uses of l-4-chlorokynurenine | |
| MX2017006513A (es) | Compuestos de tipo 1,9-diazaespiroundecano con actividad multimodal contra el dolor. | |
| MX2016006603A (es) | Compuestos piperidinicos con actividad multimodal contra el dolor. | |
| PH12018500814A1 (en) | Oxadiazaspiro compounds for the treatment of drug abuse and addiction | |
| PH12018502280A1 (en) | Tetrahydropyran and thiopyran derivatives having multimodal activity against pain | |
| IN2013MU03118A (enExample) | ||
| PH12018500682A1 (en) | Oxa-diazaspiro compounds having activity against pain | |
| MX2018004774A (es) | Derivados de morfolina sustituidos que tienen actividad contra el dolor. | |
| MX2018000418A (es) | Derivados de amida que tienen actividad multimodal contra el dolor. | |
| HK1241862A1 (en) | 1,9-diazaspiro undecane compounds having multimodal activity against pain | |
| HK1244003A1 (en) | Spiro-isoquinoline-1,4'-piperidine compounds having multimodal activity against pain | |
| MX2018004776A (es) | Compuestos oxaazaespiricos con actividad contral el dolor. | |
| HK1235774A1 (en) | Alkyl derivatives of 1-oxa-4,9-diazaspiro undecane compounds having multimodal activity against pain |